nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—SLC6A4—conduct disorder	0.489	0.565	CbGaD
Nortriptyline—HTR2A—conduct disorder	0.376	0.434	CbGaD
Nortriptyline—ORM1—saliva—conduct disorder	0.0075	0.252	CbGeAlD
Nortriptyline—SLC6A2—autonomic nervous system—conduct disorder	0.00576	0.193	CbGeAlD
Nortriptyline—HTR2A—autonomic nervous system—conduct disorder	0.00346	0.116	CbGeAlD
Nortriptyline—CHRM4—brain—conduct disorder	0.00129	0.0433	CbGeAlD
Nortriptyline—HTR6—brain—conduct disorder	0.00115	0.0388	CbGeAlD
Nortriptyline—CHRM5—brain—conduct disorder	0.00101	0.0339	CbGeAlD
Nortriptyline—Protriptyline—SLC6A4—conduct disorder	0.000953	0.12	CrCbGaD
Nortriptyline—ADRA1B—brain—conduct disorder	0.000921	0.0309	CbGeAlD
Nortriptyline—ADRA1D—brain—conduct disorder	0.000901	0.0303	CbGeAlD
Nortriptyline—CHRM2—brain—conduct disorder	0.000692	0.0232	CbGeAlD
Nortriptyline—HTR2C—brain—conduct disorder	0.000667	0.0224	CbGeAlD
Nortriptyline—ALB—brain—conduct disorder	0.000651	0.0219	CbGeAlD
Nortriptyline—SLC6A4—brain—conduct disorder	0.000632	0.0212	CbGeAlD
Nortriptyline—CHRM1—brain—conduct disorder	0.00063	0.0212	CbGeAlD
Nortriptyline—CHRM3—brain—conduct disorder	0.000564	0.0189	CbGeAlD
Nortriptyline—HTR1A—brain—conduct disorder	0.000561	0.0189	CbGeAlD
Nortriptyline—SLC6A2—brain—conduct disorder	0.000557	0.0187	CbGeAlD
Nortriptyline—Cyclobenzaprine—HTR2A—conduct disorder	0.000547	0.0687	CrCbGaD
Nortriptyline—Epinastine—HTR2A—conduct disorder	0.000543	0.0682	CrCbGaD
Nortriptyline—ADRA1A—brain—conduct disorder	0.000518	0.0174	CbGeAlD
Nortriptyline—DRD2—brain—conduct disorder	0.000507	0.017	CbGeAlD
Nortriptyline—Maprotiline—HTR2A—conduct disorder	0.000467	0.0587	CrCbGaD
Nortriptyline—Atomoxetine—SLC6A4—conduct disorder	0.000418	0.0526	CrCbGaD
Nortriptyline—Cyproheptadine—HTR2A—conduct disorder	0.000414	0.0521	CrCbGaD
Nortriptyline—Mianserin—SLC6A4—conduct disorder	0.000409	0.0514	CrCbGaD
Nortriptyline—HRH1—brain—conduct disorder	0.000401	0.0135	CbGeAlD
Nortriptyline—CYP2E1—brain—conduct disorder	0.000385	0.0129	CbGeAlD
Nortriptyline—Clomipramine—SLC6A4—conduct disorder	0.000374	0.047	CrCbGaD
Nortriptyline—PTGS1—brain—conduct disorder	0.000371	0.0125	CbGeAlD
Nortriptyline—Trimipramine—SLC6A4—conduct disorder	0.000344	0.0432	CrCbGaD
Nortriptyline—HTR2A—brain—conduct disorder	0.000335	0.0112	CbGeAlD
Nortriptyline—Doxepin—SLC6A4—conduct disorder	0.000328	0.0412	CrCbGaD
Nortriptyline—Atomoxetine—HTR2A—conduct disorder	0.000321	0.0404	CrCbGaD
Nortriptyline—Mianserin—HTR2A—conduct disorder	0.000314	0.0395	CrCbGaD
Nortriptyline—CYP2D6—brain—conduct disorder	0.000305	0.0102	CbGeAlD
Nortriptyline—Desipramine—SLC6A4—conduct disorder	0.000301	0.0378	CrCbGaD
Nortriptyline—Clomipramine—HTR2A—conduct disorder	0.000287	0.0361	CrCbGaD
Nortriptyline—Chlorprothixene—HTR2A—conduct disorder	0.000286	0.036	CrCbGaD
Nortriptyline—Trimipramine—HTR2A—conduct disorder	0.000264	0.0332	CrCbGaD
Nortriptyline—Imipramine—SLC6A4—conduct disorder	0.000255	0.0321	CrCbGaD
Nortriptyline—Amitriptyline—SLC6A4—conduct disorder	0.000253	0.0319	CrCbGaD
Nortriptyline—Doxepin—HTR2A—conduct disorder	0.000252	0.0317	CrCbGaD
Nortriptyline—Desipramine—HTR2A—conduct disorder	0.000231	0.0291	CrCbGaD
Nortriptyline—Imipramine—HTR2A—conduct disorder	0.000196	0.0246	CrCbGaD
Nortriptyline—Amitriptyline—HTR2A—conduct disorder	0.000195	0.0245	CrCbGaD
Nortriptyline—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.000107	0.0011	CbGpPWpGaD
Nortriptyline—CYP2C19—Biological oxidations—COMT—conduct disorder	0.000107	0.0011	CbGpPWpGaD
Nortriptyline—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.000106	0.00109	CbGpPWpGaD
Nortriptyline—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.000105	0.00109	CbGpPWpGaD
Nortriptyline—SLC6A4—Circadian rythm related genes—EP300—conduct disorder	0.000104	0.00107	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—CGA—conduct disorder	0.000103	0.00106	CbGpPWpGaD
Nortriptyline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000102	0.00106	CbGpPWpGaD
Nortriptyline—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000102	0.00106	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—CGA—conduct disorder	0.000102	0.00105	CbGpPWpGaD
Nortriptyline—ALB—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000101	0.00104	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—CGA—conduct disorder	9.93e-05	0.00102	CbGpPWpGaD
Nortriptyline—HTR6—GPCR ligand binding—HTR2A—conduct disorder	9.88e-05	0.00102	CbGpPWpGaD
Nortriptyline—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.84e-05	0.00102	CbGpPWpGaD
Nortriptyline—DRD2—GPCR ligand binding—DRD4—conduct disorder	9.84e-05	0.00102	CbGpPWpGaD
Nortriptyline—CYP2D6—Biological oxidations—COMT—conduct disorder	9.81e-05	0.00101	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—CGA—conduct disorder	9.78e-05	0.00101	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—CGA—conduct disorder	9.77e-05	0.00101	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—CGA—conduct disorder	9.75e-05	0.00101	CbGpPWpGaD
Nortriptyline—CYP2D6—Biological oxidations—MAOA—conduct disorder	9.74e-05	0.001	CbGpPWpGaD
Nortriptyline—CYP2C9—Biological oxidations—COMT—conduct disorder	9.73e-05	0.001	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—CGA—conduct disorder	9.72e-05	0.001	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—CGA—conduct disorder	9.69e-05	0.000999	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR ligand binding—DRD4—conduct disorder	9.68e-05	0.000999	CbGpPWpGaD
Nortriptyline—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	9.68e-05	0.000998	CbGpPWpGaD
Nortriptyline—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.66e-05	0.000997	CbGpPWpGaD
Nortriptyline—HRH1—GPCR ligand binding—DRD4—conduct disorder	9.66e-05	0.000997	CbGpPWpGaD
Nortriptyline—CYP2C9—Biological oxidations—MAOA—conduct disorder	9.66e-05	0.000996	CbGpPWpGaD
Nortriptyline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.63e-05	0.000994	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR ligand binding—DRD4—conduct disorder	9.63e-05	0.000994	CbGpPWpGaD
Nortriptyline—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.6e-05	0.000991	CbGpPWpGaD
Nortriptyline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.6e-05	0.00099	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR ligand binding—DRD4—conduct disorder	9.6e-05	0.00099	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—CGA—conduct disorder	9.6e-05	0.00099	CbGpPWpGaD
Nortriptyline—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	9.59e-05	0.000989	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	9.57e-05	0.000987	CbGpPWpGaD
Nortriptyline—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.56e-05	0.000986	CbGpPWpGaD
Nortriptyline—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.51e-05	0.000981	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR ligand binding—DRD4—conduct disorder	9.51e-05	0.000981	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.48e-05	0.000978	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	9.48e-05	0.000978	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR ligand binding—HTR2A—conduct disorder	9.32e-05	0.000961	CbGpPWpGaD
Nortriptyline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.15e-05	0.000943	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	9.07e-05	0.000936	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—CGA—conduct disorder	9.02e-05	0.00093	CbGpPWpGaD
Nortriptyline—ALB—Transmembrane transport of small molecules—GABRA2—conduct disorder	9.01e-05	0.00093	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR ligand binding—HTR2A—conduct disorder	8.93e-05	0.000921	CbGpPWpGaD
Nortriptyline—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	8.88e-05	0.000916	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—CGA—conduct disorder	8.87e-05	0.000915	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—CGA—conduct disorder	8.86e-05	0.000913	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—CGA—conduct disorder	8.83e-05	0.00091	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—CGA—conduct disorder	8.8e-05	0.000908	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—CGA—conduct disorder	8.71e-05	0.000899	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—CGA—conduct disorder	8.69e-05	0.000896	CbGpPWpGaD
Nortriptyline—HTR6—GPCR downstream signaling—DRD4—conduct disorder	8.56e-05	0.000883	CbGpPWpGaD
Nortriptyline—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.43e-05	0.00087	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	8.39e-05	0.000866	CbGpPWpGaD
Nortriptyline—CYP1A2—Biological oxidations—COMT—conduct disorder	8.31e-05	0.000857	CbGpPWpGaD
Nortriptyline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.28e-05	0.000854	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	8.27e-05	0.000853	CbGpPWpGaD
Nortriptyline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.25e-05	0.000851	CbGpPWpGaD
Nortriptyline—CYP1A2—Biological oxidations—MAOA—conduct disorder	8.25e-05	0.000851	CbGpPWpGaD
Nortriptyline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.23e-05	0.000849	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CGA—conduct disorder	8.2e-05	0.000846	CbGpPWpGaD
Nortriptyline—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	8.2e-05	0.000845	CbGpPWpGaD
Nortriptyline—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.15e-05	0.00084	CbGpPWpGaD
Nortriptyline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.12e-05	0.000838	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR downstream signaling—DRD4—conduct disorder	8.07e-05	0.000833	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—DRD4—conduct disorder	7.77e-05	0.000802	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CGA—conduct disorder	7.73e-05	0.000798	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR downstream signaling—DRD4—conduct disorder	7.73e-05	0.000797	CbGpPWpGaD
Nortriptyline—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	7.67e-05	0.000791	CbGpPWpGaD
Nortriptyline—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	7.53e-05	0.000777	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CGA—conduct disorder	7.41e-05	0.000764	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—DRD4—conduct disorder	7.33e-05	0.000756	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	7.31e-05	0.000754	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	7.28e-05	0.000751	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	7.27e-05	0.00075	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	7.07e-05	0.000729	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—DRD4—conduct disorder	7.02e-05	0.000724	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—CGA—conduct disorder	7.01e-05	0.000723	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	6.97e-05	0.000718	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CGA—conduct disorder	6.96e-05	0.000718	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	6.6e-05	0.000681	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—WASF1—conduct disorder	6.57e-05	0.000678	CbGpPWpGaD
Nortriptyline—DRD2—GPCR ligand binding—HTR2A—conduct disorder	6.42e-05	0.000662	CbGpPWpGaD
Nortriptyline—CYP3A4—Biological oxidations—COMT—conduct disorder	6.41e-05	0.000662	CbGpPWpGaD
Nortriptyline—CYP3A4—Biological oxidations—MAOA—conduct disorder	6.37e-05	0.000657	CbGpPWpGaD
Nortriptyline—DRD2—Circadian rythm related genes—EP300—conduct disorder	6.37e-05	0.000657	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	6.33e-05	0.000653	CbGpPWpGaD
Nortriptyline—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	6.33e-05	0.000653	CbGpPWpGaD
Nortriptyline—HRH1—GPCR ligand binding—HTR2A—conduct disorder	6.3e-05	0.00065	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	6.3e-05	0.00065	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	6.28e-05	0.000648	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	6.26e-05	0.000646	CbGpPWpGaD
Nortriptyline—CHRM1—Circadian rythm related genes—EP300—conduct disorder	6.23e-05	0.000643	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—CGA—conduct disorder	6.22e-05	0.000641	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	6.2e-05	0.00064	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—WASF1—conduct disorder	6.2e-05	0.000639	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	6.19e-05	0.000638	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CGA—conduct disorder	6.07e-05	0.000626	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CGA—conduct disorder	6.04e-05	0.000623	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	6.03e-05	0.000622	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—WASF1—conduct disorder	5.94e-05	0.000612	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CGA—conduct disorder	5.78e-05	0.000596	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—DRD4—conduct disorder	5.75e-05	0.000593	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—DRD4—conduct disorder	5.72e-05	0.00059	CbGpPWpGaD
Nortriptyline—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	5.58e-05	0.000576	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—WASF1—conduct disorder	5.58e-05	0.000576	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—DRD4—conduct disorder	5.56e-05	0.000574	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	5.48e-05	0.000565	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	5.47e-05	0.000564	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—DRD4—conduct disorder	5.46e-05	0.000563	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	5.44e-05	0.000561	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	5.43e-05	0.00056	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	5.37e-05	0.000554	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	5.36e-05	0.000553	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CGA—conduct disorder	5.33e-05	0.00055	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR downstream signaling—HTR2A—conduct disorder	5.27e-05	0.000543	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CGA—conduct disorder	5.24e-05	0.000541	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—CGA—conduct disorder	5.24e-05	0.00054	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CGA—conduct disorder	5.23e-05	0.00054	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—CGA—conduct disorder	5.23e-05	0.000539	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CGA—conduct disorder	5.21e-05	0.000538	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CGA—conduct disorder	5.2e-05	0.000536	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CGA—conduct disorder	5.15e-05	0.000531	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CGA—conduct disorder	5.13e-05	0.000529	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—HTR2A—conduct disorder	5.07e-05	0.000523	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—DRD4—conduct disorder	5.05e-05	0.000521	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR downstream signaling—HTR2A—conduct disorder	5.04e-05	0.00052	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—DRD4—conduct disorder	4.97e-05	0.000513	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—DRD4—conduct disorder	4.96e-05	0.000512	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—DRD4—conduct disorder	4.94e-05	0.00051	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—DRD4—conduct disorder	4.93e-05	0.000508	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—DRD4—conduct disorder	4.88e-05	0.000503	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	4.87e-05	0.000502	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—WASF1—conduct disorder	4.86e-05	0.000502	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—WASF1—conduct disorder	4.84e-05	0.000499	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—HTR2A—conduct disorder	4.78e-05	0.000493	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	4.74e-05	0.000489	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—WASF1—conduct disorder	4.63e-05	0.000478	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—DRD4—conduct disorder	4.59e-05	0.000474	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—HTR2A—conduct disorder	4.58e-05	0.000472	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CGA—conduct disorder	4.5e-05	0.000464	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—DRD4—conduct disorder	4.33e-05	0.000447	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	4.31e-05	0.000444	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—WASF1—conduct disorder	4.27e-05	0.00044	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—WASF1—conduct disorder	4.2e-05	0.000433	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—WASF1—conduct disorder	4.19e-05	0.000432	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—WASF1—conduct disorder	4.18e-05	0.000431	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—WASF1—conduct disorder	4.17e-05	0.00043	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—DRD4—conduct disorder	4.15e-05	0.000428	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	4.13e-05	0.000426	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—WASF1—conduct disorder	4.13e-05	0.000426	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—WASF1—conduct disorder	4.11e-05	0.000424	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	4.11e-05	0.000424	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CGA—conduct disorder	4.04e-05	0.000417	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	3.94e-05	0.000406	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—DRD4—conduct disorder	3.9e-05	0.000402	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	3.75e-05	0.000387	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	3.73e-05	0.000385	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CGA—conduct disorder	3.72e-05	0.000383	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CGA—conduct disorder	3.68e-05	0.00038	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	3.63e-05	0.000374	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	3.57e-05	0.000369	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	3.56e-05	0.000368	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	3.55e-05	0.000366	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	3.54e-05	0.000365	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	3.51e-05	0.000362	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	3.5e-05	0.000361	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—DRD4—conduct disorder	3.4e-05	0.000351	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—DRD4—conduct disorder	3.38e-05	0.000349	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—HTR2A—conduct disorder	3.3e-05	0.00034	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—DRD4—conduct disorder	3.24e-05	0.000334	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—HTR2A—conduct disorder	3.24e-05	0.000334	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	3.23e-05	0.000333	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	3.21e-05	0.000332	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	3.18e-05	0.000328	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	3.18e-05	0.000327	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—COMT—conduct disorder	3.16e-05	0.000326	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CGA—conduct disorder	3.15e-05	0.000325	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—MAOA—conduct disorder	3.14e-05	0.000324	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	3.05e-05	0.000314	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—HTR2A—conduct disorder	3e-05	0.000309	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—DRD4—conduct disorder	2.98e-05	0.000308	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.94e-05	0.000303	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—DRD4—conduct disorder	2.93e-05	0.000302	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—DRD4—conduct disorder	2.92e-05	0.000301	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—DRD4—conduct disorder	2.91e-05	0.0003	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—DRD4—conduct disorder	2.88e-05	0.000297	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—DRD4—conduct disorder	2.87e-05	0.000297	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—HTR2A—conduct disorder	2.83e-05	0.000291	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—COMT—conduct disorder	2.81e-05	0.000289	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—MAOA—conduct disorder	2.79e-05	0.000287	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—HTR2A—conduct disorder	2.71e-05	0.000279	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	2.54e-05	0.000262	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CGA—conduct disorder	2.43e-05	0.000251	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—COMT—conduct disorder	2.36e-05	0.000244	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—COMT—conduct disorder	2.36e-05	0.000243	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—MAOA—conduct disorder	2.35e-05	0.000242	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—MAOA—conduct disorder	2.34e-05	0.000242	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—HTR2A—conduct disorder	2.22e-05	0.000229	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—HTR2A—conduct disorder	2.21e-05	0.000228	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—EP300—conduct disorder	2.15e-05	0.000222	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	2.11e-05	0.000218	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—COMT—conduct disorder	2.03e-05	0.00021	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—MAOA—conduct disorder	2.02e-05	0.000208	CbGpPWpGaD
Nortriptyline—ALB—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.96e-05	0.000202	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.95e-05	0.000201	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.91e-05	0.000197	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HTR2A—conduct disorder	1.91e-05	0.000197	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HTR2A—conduct disorder	1.9e-05	0.000196	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HTR2A—conduct disorder	1.88e-05	0.000194	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.88e-05	0.000193	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—COMT—conduct disorder	1.82e-05	0.000188	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—MAOA—conduct disorder	1.81e-05	0.000187	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.76e-05	0.000181	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—COMT—conduct disorder	1.68e-05	0.000173	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—MAOA—conduct disorder	1.67e-05	0.000172	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—COMT—conduct disorder	1.66e-05	0.000172	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—MAOA—conduct disorder	1.65e-05	0.00017	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.6e-05	0.000165	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—EP300—conduct disorder	1.59e-05	0.000164	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—EP300—conduct disorder	1.5e-05	0.000154	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—EP300—conduct disorder	1.43e-05	0.000148	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—COMT—conduct disorder	1.42e-05	0.000147	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—MAOA—conduct disorder	1.41e-05	0.000146	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.37e-05	0.000141	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—EP300—conduct disorder	1.36e-05	0.00014	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—EP300—conduct disorder	1.35e-05	0.000139	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—EP300—conduct disorder	1.2e-05	0.000124	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—EP300—conduct disorder	1.17e-05	0.000121	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—EP300—conduct disorder	1.17e-05	0.000121	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—EP300—conduct disorder	1.12e-05	0.000115	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—COMT—conduct disorder	1.1e-05	0.000113	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MAOA—conduct disorder	1.09e-05	0.000112	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EP300—conduct disorder	1.03e-05	0.000106	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EP300—conduct disorder	1.01e-05	0.000105	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—EP300—conduct disorder	1.01e-05	0.000105	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EP300—conduct disorder	1.01e-05	0.000104	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—EP300—conduct disorder	1.01e-05	0.000104	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EP300—conduct disorder	1.01e-05	0.000104	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EP300—conduct disorder	1.01e-05	0.000104	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EP300—conduct disorder	9.96e-06	0.000103	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EP300—conduct disorder	9.94e-06	0.000102	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—EP300—conduct disorder	8.71e-06	8.99e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—EP300—conduct disorder	7.82e-06	8.07e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—EP300—conduct disorder	7.19e-06	7.42e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—EP300—conduct disorder	7.13e-06	7.36e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—EP300—conduct disorder	6.1e-06	6.29e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—EP300—conduct disorder	4.7e-06	4.85e-05	CbGpPWpGaD
